INTRODUCTION
Heparan sulfate (HS) is a linear, highly sulfated polysaccharide composed of glucosamine and hexauronic acid disaccharide repeating units (1) . HS covalently attaches to core proteins to form HS proteoglycans (HSPG). Dictated by the location of the core proteins, HS chains present on cell surfaces, such as linking to syndecans and glypicans, and in the basement membrane by attaching to perlecan and agrin (1) (2) (3) . HS biosynthesis is initiated by heterodimers formed by co-polymerases Exostosin-1 (Ext1) and Exostosin-2 (Ext2) that elongate HS chains by alternatively adding glucuronic acid (GlcA) and N-acetylglucosamine (4) . The FGF2 binding site is a short sulfated sequence with N-and 2-Osulfation (5) . Intriguingly, the generation of the ligand-binding sites is cell/tissue-and developmentally stage-specific, implying that the regulatory functions of HS occur in a temporal and spatial manner (6, 7) .
Endothelial cells are one of the major cellular components of blood vessels that form the inner monolayer endothelium of blood vessels. Under normal physiological conditions, endothelial cells maintain vascular homeostasis and respond to environmental changes to regulate inflammatory and immune response, vascular tone, coagulation and fibrinolysis (8) . Endothelial cells are also key players in angiogenesis that is finely tuned by the balance between pro-and anti-angiogenic factors (9) . Angiogenesis plays an essential role in physiological conditions such as embryonic development, menstruation and wound healing, as well as in pathological conditions such as tumor growth, inflammatory disorders, eye diseases, stroke, etc. (10) .
Therefore, understanding the mechanisms that control endothelial cell functions will greatly advance us to develop effective treatment for vascular related human diseases.
HS is expressed abundantly in vasculature. Genetic studies have established that HS is essentially required for endothelial cell functions at both physiological and pathological conditions (11) . We previously reported that endothelial-specific knockout of Ndst1 attenuates leukocyte adhesion and extravasation in inflammation (12) , revealing that endothelial HS is required to facilitate leukocyte trafficking. This observation was confirmed by examining the same mutant mice by others (13, 14) and by endothelial-specific ablation of Ext1 (15) or HS 2-O-sulfotranserase (16) . We also observed that deficiency of endothelial Ndst1 retards tumorigenesis (11) , showing that endothelial HS critically promotes tumor angiogenesis.
Recent studies by others also revealed that endothelial HS functions to promote vascular permeability (17) and tumor metastasis to lymph nodes (18) . These studies illustrate HS to be a multi-functional molecule in vivo. To understand the underlying molecular mechanisms of HS on aforementioned endothelial cell functions, we and others in general approached to examine the interactions of endothelial HS with one or a few HS-binding ligands that are known to critically involve in the studied biological functions. For example, we examined the interactions of endothelial HS with L-selectin and three chemokines in leukocyte trafficking study (12) , and the VEGF signaling in tumor angiogenesis (11) . Similarly, only VEGF and neuropilin signaling were examined in examining the regulatory role of endothelial HS in vascular permeability (17) , and only two chemokines were checked in the study of tumor metastasis to lymph nodes (18) . This specific molecule targeting approach allowed us to understand some key underlying molecular mechanisms. However, in reality, a large number of HS-binding growth factors, morphogens, cytokines and adhesion molecules are expected to co-express at the examined conditions and HS may selectively interact with a fraction of these HS-binding protein ligands to modulate endothelial functions (3, 19) . To fully understand the molecular mechanisms behind, an unbiased analysis is essentially needed to determine the cell-specific and spatiotemporal regulatory roles of HS on endothelial cell function and related signaling.
Regulatory post-translational modification represents a major cellular signaling mechanism that allows cells to sense environmental change. Among them, reversible phosphorylation controlled by kinases and phosphatases plays a central role in signaling in cell-cell or cell-environment communication (20) . Global phosphoproteomics examines phosphorylation changes, thereby unbiasedly determines signaling regulation at a systemic level (21, 22) . In this study, we applied the stable isotope labeling by amino acids (SILAC)-based global quantitative phosphoproteomics analysis to examine HS-dependent endothelial signaling by comparing wildtype and HS-deficient endothelial cells that were cultured at serum-containing condition. A total of 7,222 phosphopeptides corresponding to 1,179 proteins were identified. Bioinformatics analysis of the identified proteins determined that HS deficiency altered cellular functions that are highly related to cell morphology, cellular assembly and organization, cellular function and maintenance, inflammatory response and disorder, cell growth and proliferation, cellular survival and death, consistent with cell function studies observed that HS deficiency alters endothelial cell growth and mobility. Mining for the underlying molecular mechanisms revealed that HS modulates signaling pathways critically related to cell adhesion, migration and coagulation, and uncovered that HS critically modulates IGF-1 signaling. In-depth analysis of growth factor signaling identified 22 HS-dependent growth factor/cytokine/growth hormone signaling, including both previously known and unknown ones such as IGF-1, erythropoietin, angiopoietin/Tie, IL-17A and growth hormones. Twelve of the identified 22 HS-dependent signaling were alternatively confirmed by phospho-receptor tyrosine kinase (p-RTK) array analysis. Therefore, our results revealed a broad and very complex regulatory role of HS on endothelial signaling.
EXPERIMENTAL PROCEDURES

Mouse and cell line
The experimental mice harboring conditionally targeted Ext1 (Ext1f/f mice) were bred onto C57BL/6J background and housed at a specific pathogen-free facility as reported previously (23, 24) . The animal protocol was approved by the Institutional Animal Care and Use Committee of the University of Georgia. Mouse lung endothelial cell (MLEC) lines were derived from 8-week-old Ext1f/f mice as described previously (12, 25) . Briefly, the lungs were minced, digested at 37°C for 1 h in DMEM supplemented with 5% FBS and various enzymes including collagenase Type II (200 U/ml, Invitrogen, Grand Island, NY), dispase (0.1%, Invitrogen) and DNAse I (10 U/ml, MP Biosciences), and filtered through a 40 µm nylon strainer. The cell suspension was added with PE-conjugated rat anti-mouse CD31 ( Tube formation (28, 29) MLECs (3×10 4 /well) in DMEM medium containing 5% FBS were seeded on 96-well plate coated with growth factor reduced matrigel. After 6 h, cell morphology in culture was photographed under the Nikon Eclipse TE2000-S inverted microscope. 
Phospho-Receptor Tyrosine Kinase (p-RTK) array assay
Protein reduction, alkylation and digestion
The reconstituted protein samples were reduced at RT for 45 min by adding 1 M DTT to a final concentration 1 mM with shaking. The sample was further subjected to alkylation in the dark for 
SCX (strong cation exchange chromatography) fraction
The lyophilized peptide mixtures were fractioned with an Agilent 1200 HPLC system as reported (33) . Briefly, the peptide mixture (6-10 mg) was resolved in Buffer A (30% acetonitrile, 7 mM KH 2 PO 4 , pH 2.65 after adjustment with TFA) and loaded onto a Resource 15S 4.6/100PE
(GE Health Science, Pittsburgh, PA) column that was pre-equilibrated with Buffer A. The loaded peptide sample was eluted out using a linear gradient of KCl ranging from 0 -350 mM by mixing
Buffer A with Buffer B (Buffer A + 350 mM KCl) at a flow rate of 1 ml/min. The eluted samples were collected for 4 min per fraction. Following, the collected fractions were combined into 10 fractions and lyophilized.
Phosphopeptide enrichment
Each fraction of the lyophilized peptides was desalted using a Sepak C18 Cartridge (Waters)
with Buffer C (0.4% TFA /60% Acetonitrile solution, 25% lactic acid) as the elution buffer.
Phosphopeptide was enriched using a TiO2 column (Titansphere PHOS-TiO Kit, GL Sciences, Torrance, Ca) (34) . Briefly, the TiO2 column was sequentially equilibrated with Buffer D (0.4% TFA /60% Acetonitrile) and Buffer C. Following, the sample in Buffer C was loaded to the column and sequentially washed with Buffer D once and then Buffer C twice. The bound phosphopeptides were eluted out with 5% ammonium hydroxide solution followed by 5% pyridine solution.
LC-MS/MS analysis
Phosphopeptides were analyzed using the Eksigent nanoLC-UltraTM2D System combined with the cHiPLCTM-Nanoflex system in Trap-Elute mode. The peptides were loaded on the cHiPLC trap (200 µm x 500 µm ChromXP C18-CL 3 µm 300 Å) and washed for 10 min at 2 µl/min. An elution gradient of 5-35% acetonitrile (0.1% formic acid) over 110 min at 300 nL/min was then applied on a nano cHiPLC column (75 µm x 15 cm ChromXP C18-CL 3 µm 300 Å). Surveys of full scan MS spectra (from m/z 375 to 1,700) were acquired in the AB SCIEX TripleTOF® 5600
System with a resolution of 40,000 for both MS and MS/MS. The 50 most intense ions (depending on signal intensity) were sequentially isolated for fragmentation in the quadrupole by collision-induced dissociation. The interface temperature was maintained at 150⁰C and the spray voltage was kept at 2500V.
Data analysis
All raw data was processed using ProteinPilot TM Software 4. were annotated with "auto-discordant peptide type" and "auto-shared MS/MS" were excluded.
All peptides and proteins were filtered with confidence to 5% FDR. The count of phosphorylation sites such as phospho-serine (p-Ser), phospho-threonine (p-Thr), and phospho-tyrosine (p-Tyr) in the datasets was calculated using in-house perl-based scripts with minor modification (36) . Peptides were defined as redundant if they had identical cleavage site(s), amino acid sequence, and modification. A score of each phosphorylation site was calculated by in-house developed python scripts to evaluate the phosphorylation site confidence. Phosphosite with A-score >10 was considered to be near certainty (37) .
Bioinformatics
Gene ontology (GO) annotation of the identified proteins was obtained using the software DAVID (38) . All quantified phosphopeptides were analyzed using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Redwood City, CA) by core analysis. The over represented biological processes, molecular functions and canonical pathways were generated based on information contained in the Ingenuity Pathways Knowledge Base. The significance of the association between the data set and the canonical pathway was measured in 2 ways: 1) A ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway is displayed. 2) Fisher's exact test was used to calculate a p-value determining the probability that the association between the genes in the data set and the canonical pathway is explained by chance alone.
RESULTS
Experimental strategy
To unambiguously determine the regulatory role of HS on endothelial cell function and related signaling, we initially tried to obtain endothelial cells that are deficient in HS expression. For this purpose, we targeted HS biosynthetic gene Ext1 to generate Ext1 null (Ext1-/-) MLEC lines with proper wildtype (Ext1f/f) control (Fig. 1A) . Secondly, SILAC-based quantitative phosphoproteomic analysis was carried out to determine phosphorylation alterations that were caused by Ext1 ablation in MLECs (Fig. 1B) .
Derivation of Ext1f/f and Ext1-/-MLEC lines
To derive Ext1-/-MLEC lines, the "mother" Ext1f/f MLEC lines were initially generated by immortalizing primary MLECs in culture and the following cell cloning (Fig. 1A) . Secondly, the Ext1f/f MLEC lines were transiently transfected with Cre-recombinase followed by single cell cloning and PCR determination of Ext1 ablation to screen for "daughter" Ext1-/-MLECs ( staining compared to isotype-matched control staining (Fig. 2B ). In contrast, there is nearly no difference in the Ext1-/-cells between 10E4 and the isotype-matched control staining (Fig. 2C) ,
showing directly that Ext1 ablation completely disrupts HS biosynthesis in the Ext1-/-MLECs.
To confirm that the derived cells are true endothelial cells, the cells were stained with antibodies specific to CD31 or VEGFR2, the two common endothelial cell markers. Both the Ext1f/f and Ext1-/-cells express high levels of CD31 and VEGFR2 on their cell surface (Fig. 2D-G Since the "daughter" Ext1-/-cells were derived from the "mother" Ext1f/f control MLECs, both cell lines have the same genetic background. Therefore, the Ext1f/f and Ext1-/-MLECs provide a genetic background and fully matched experimental system allowing us to vigorously determine the regulatory role of HS on endothelial cell function and related signaling.
HS regulates endothelial cell functions
To determine whether HS essentially modulates cell functions of the derived MLECs under physiological condition (Fig. 1A) , we initially examined the proliferation rate of the Ext1f/f and Ext1-/-MLECs cultured in FBS-containing DMEM, the medium routinely used in the cell culture.
At 10% FBS containing condition, the Ext1-/-MLECs appeared to grow slower compared to
Ext1f/f cells, but the difference was not statistically significant (Fig. S1) . Whereas, when FBS concentration was reduced to 1%, the growth retardation of Ext1-/-MLECs became highly significant (Fig. 3A) . Furthermore, the growth retardation could be partially rescued by supplementing the culture with heparin, a highly sulfated form of HS (Fig. 3A ). These observations demonstrate that HS essentially promotes endothelial cell growth.
High mobility is critically required for some endothelial cell-mediated biological processes, such as vessel sprouting to form new vasculature during angiogenesis. Therefore, we further determined whether HS modulates mobility of endothelial cells. Cell motility includes two types of cell movement, the autonomous migration and chemotaxis. We initially determined whether less Ext1-/-MLECs migrated across the trans-well membrane ( Fig. 3D-E) . Parallel experiments showed that supplementing heparin in culture was close to fully rescuing the defects of wound healing and trans-well migration of the Ext1-/-MLECs, confirming that the cell mobility defects are due to HS deficiency ( Fig. 3B-E) . Together, these observations demonstrated that HS potently enhances both autonomous migration and chemotaxis to promote endothelial cell mobility.
One unique functional feature of endothelial cells is their capability to form capillary-like structures on matrigel, a multi-step vascular morphogenesis process involving cell adhesion, migration and growth. To assess whether HS modulates this complex vascular morphogenesis process, Ext1f/f and Ext1-/-MLECs were seeded and cultured on matrigel-coated wells. At this culture condition, Ext1f/f MLECs formed long and well-linked tubule-like structures within 6 h, whereas in sharp contrast, the Ext1-/-cells remained individually or as a few cells clustered together forming short and disconnected tubular structures, and the tube formation defect could be potently rescued by heparin supplement in culture (Fig. 3F-G) . Consistent with this observation, under normal culture condition without matrigel, the Ext1f/f MLECs formed tubular structures after reaching confluence, whereas, the Ext1-/-MLECs remained at all times as a sheet-like monolayer (Fig. S2 ). These observations are in agreement with the afore-observed pro-migratory role of HS on endothelial cell mobility. Together, these observations show that HS critically modulates endothelial cell functions and also demonstrate that the Ext1f/f and Ext1-/-
MLECs are a new cell model system to use to investigate the role of HS in endothelial signaling.
Quantitative phosphosproteomic profiling of Ext1f/f and Ext1-/-MLECs
To systematically analyze the regulatory role of HS in endothelial signaling, we employed SILAC-based quantitative phosphoproteomic analysis. Phosphopeptides were prepared and analyzed in triplicate as detailed in the Experimental Procedures section. Phosphopeptides with minimum confidence of 90%, that were determined by ProteinPilot, were accepted according to a previous report (40) . We cannot set missed and/or non-specific cleavages permitted parameter in the ProteinPilotTM software for the triple TOF5600 data. From the results, we can see at least two missed and/or non-specific cleavages. A total of 7,222 unique phosphopeptides, which correspond to 1,179 proteins, were identified in both Ext1f/f and Ext1-/-MLECs (Table S1 ). Among them, there were 2831 distinct peptides corresponding to the 884 proteins quantified using the ProteinPilot TM Software (Table S2) https://db.systemsbiology.net/sbeams/cgi/PeptideAtlas/PASS_View?identifier=PASS00235.
Functional distribution of identified phosphoproteins
To understand the biological functions of the proteins identified, we performed GO analysis of the identified phosphoproteins. There are three main GO categories, namely, cellular component, molecular function and biological process. The GO enrichment was accomplished using the software DAVID and revealed that most of the identified proteins are associated with organelles, cytoskeleton, plasma membrane and cytosol (Fig. 4A) . The most relevant biological processes identified include transcription control, protein location and translation, intracellular signaling cascade, phosphorylation and phosphorylate metabolism, cell cycle, cell death and transportation (Fig. 4B ). Consistent with these findings, the GO analysis of molecular functions further revealed that the identified proteins were tightly related to the binding of various nucleotides, kinase activity and transcription regulator activity (Fig. 4C ).
Functional signaling network modulated by HS
To decipher endothelial signaling regulated by HS, we performed core analysis of the quantified phosphopeptides using the Ingenuity Pathway Analysis (IPA) software. In total, 25 functional networks were identified to be HS dependent. The top five identified functional networks include cell morphology, cellular assembly and organization, cellular function and maintenance, inflammatory response and disorder, cell growth and proliferation, cellular survival and death (Table 1 ). In addition to the specific networks, multiple canonical signaling pathways that have been known to be modulated by HS were also identified, such as VEGF and FGF signaling, thus verifying the credibility of the data analysis of the IPA software (Fig. S3) . Surprisingly, the top HS-dependent signaling identified is IGF-1 signaling, which previously had not been known to be HS-dependent. In addition, adhesion signaling was also identified in the top-ranked HSdependent signaling, including FAK signaling and integrin signaling (Fig. S3) . Meanwhile, HS was identified to modulate other signaling critically related to endothelial cell mobility, including actin cytoskeleton organization and cell junction (Fig. S3) . Furthermore, the thrombin signaling, a key process in blood coagulation, was observed to be altered (Fig. S3 ), indicating that HS may critically modulate hemostatic competency of endothelial cells.
HS-modulated growth factor signaling
Several growth factors, such as VEGF, essentially modulate the basic cellular functions of endothelial cells as afore-examined in this study. Therefore, specific attention was paid to examine growth factor signaling modulated by HS. The IPA analysis determined that, compared to Ext1f/f MLECs, 22 growth factor/cytokine/growth hormone signaling pathways were altered in the Ext1-/-cells, including the well-documented HS-dependent signaling such as VEGF, FGF, PDGF, TGFβ, HGF, GM-CSF and neuregulin/ErbB (Fig. 5A ). This analysis also revealed several signals that have not been known to be HS-dependent, including IGF-1, erythropoietin, angiopoietin/Tie, IL-17A and growth hormones (Fig. 5A) . To alternatively confirm these findings, we carried out mouse p-RTK array analysis. The p-RTK array examined 39 different phosphorylated mouse RTKs and included 12 signaling pathways that were identified in our phosphoproteomics analysis to be HS-dependent (Fig.5A, Fig. S3 and Table 2 (Fig. 6C) . However, IGF-1 is a non-HS-binding protein (43) and Ext1 ablation does not alter IFG1R expression (Fig. 6B) , therefore the diminished cell Our detailed analysis of growth factor signaling revealed 22 growth factor/cytokine/growth hormone signaling pathways that were modulated by HS, including several signaling pathways that have not been known to be HS-dependent, including IGF-1, erythropoietin, angiopoietin/Tie, IL-17A and growth hormones. In summary, this SILAC-based phosphoproteomic analysis confirmed previous findings and also uncovered novel HSdependent functional networks and signaling, thus advancing our understanding of the regulatory role of HS on endothelial function and the underlying molecular mechanisms from a systematic view.
In this study, many pathways were identified to be HS-dependent (Fig. S3) , reflecting the complexity of the regulatory roles of HS on endothelial cell function and signaling at systematic levels. This general observation is consistent with the complex heterogeneous HS structural features that enables HS to interact with a large number of growth factors, growth factor binding proteins, extracellular proteases, protease inhibitors, chemokines, morphogens and adhesive proteins. Sorting the identified signaling pathways revealed that the top ranked HS-dependent signaling pathways were IGF-1 signaling, integrin signaling and signaling related to actin cytoskeleton organization and cell junction. These top ranked signaling pathways are critically related to cell proliferation, apoptosis, cell adhesion and migration (Fig.S3) , and are directly correlated with the cell status in culture where the MLECs are at the exponential growth phase undergoing active cell proliferation and migration. These observations lead us to reason that HS deficiency impairs cell proliferation, cell adhesion and migration signaling, resulting in arrested cell growth, mobility and tube formation of the Ext1-/-MLECs as observed in our cell function studies (Fig. 3) .
Our studies are in agreement with a recent study reporting that HS and heparin, a highly sulfated form of HS, bind a large number of proteins to form a highly interconnected network, which is functionally linked to physiological and pathological processes (47) . In this study, we We have noticed that the most of the identified HS-dependent signaling pathways, either their ligand/receptor or their modulatory components bind HS. Therefore, we presumably believe that most of these identified HS-dependent signaling pathways are directly modulated by HS.
However, Ext1 ablation has been shown to stimulate chondroitin sulfate expression, which has the potential to affect a lot of signaling too (51) . Therefore, we also postulate that some of the 
